2022/07
2022/04 2022/02 2022/01 2021/11 | KriSan Biotech will attend Bio Asia Taiwan, 2022/7/28 – 2021/7/31. Booth No.: S610
Passed “Southern Science Park Emerging Technology Application Plan” Develop CpG1018 successfully and provide samples to the potential customers. Passed GMP follow-up inspection by TFDA KriSan Biotech will attend Bio Asia Taiwan, 2021/11/04 – 2021/11/07. Booth No.: R714 |
| 2019/09 | KriSan Biotech as a CDMO partner supplies Kg-scale of API to Atossa Genetic(NASDAQ: ATOS) from Pre-IND to Phase 2. |
| 2019/09 | KriSan Biotech and OncoArendi Therapeutic (OAT) have entered into an agreement of API supply from Pre-IND to Phase 2. |
2019/06 |  |
| 2019/03 | Ms. Wang Yu Pei acts as President of KriSan Biotech Co., Ltd. |
2019/03 |
Congratulations!! KriSan Biotech obtained PICS/GMP certificate for pilot plant |
| 2018/12 | KSB obtain Health Workplace certification from Ministry of Health and Welfare |
  |
| 2018/10 | 2018 CPhI worldwide https://www.cphi.com/europe/ |
 |
| 2018/06 | 2018 CPhI China https://www.cphi.com/china/visit |
 |
| 2018/03 | Deliver oncology generic API to Japan |
| 2017/12 | Obtain Japan Accreditation certificate of foreign drug manufacturer. Number of accreditation: AG10600073 |
| 2017/07 | The Industrial Development Bureau, Taiwan Ministry of Economic Affairs(MOEA) has announced that “KriSan Biotech Co., Ltd.” is recommended as domestic pharmaceutical R & D services provider in Taiwan biotech pharmaceutical industry. https://www.moeaidb.gov.tw/external/ctlr?PRO=application.ApplicationView&id=49 |